These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38402922)

  • 1. Prognostic Impact of Previous Atherosclerotic Cardiovascular Disease on Short- and Long-Term Outcomes in Acute Myocardial Infarction.
    Saito Y; Yaginuma H; Asada K; Goto H; Sato T; Kitahara H; Kobayashi Y
    Am J Cardiol; 2024 Apr; 217():18-24. PubMed ID: 38402922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.
    Budoff MJ; Kinninger A; Gransar H; Achenbach S; Al-Mallah M; Bax JJ; Berman DS; Cademartiri F; Callister TQ; Chang HJ; Chow BJW; Cury RC; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann PA; Leipsic J; Lin FY; Kim YJ; Marques H; Pontone G; Rubinshtein R; Shaw LJ; Villines TC; Min JK;
    JACC Cardiovasc Imaging; 2023 Sep; 16(9):1181-1189. PubMed ID: 37227328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
    Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review.
    Rahman H; Khan SU; Lone AN; Ghosh P; Kunduru M; Sharma S; Sattur S; Kaluski E
    J Am Heart Assoc; 2023 Aug; 12(16):e030578. PubMed ID: 37581396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry.
    Hejjaji V; Ellerbeck EF; Jones PG; Pacheco CM; Malik AO; Chan PS; Spertus JA; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009960. PubMed ID: 38318702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review.
    Cherepanov D; Bentley TGK; Hsiao W; Xiang P; O'Neill F; Qian Y; Yurgin N; Beenhouwer D
    Curr Med Res Opin; 2018 Mar; 34(3):459-473. PubMed ID: 29105492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Family History Increases the Risk of Disease Recurrence After a First Myocardial Infarction.
    Wahrenberg A; Kuja-Halkola R; Magnusson PKE; Häbel H; Warnqvist A; Hambraeus K; Jernberg T; Svensson P
    J Am Heart Assoc; 2021 Dec; 10(23):e022264. PubMed ID: 34845931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Calcium and Long-Term Risk of Death, Myocardial Infarction, and Stroke: The Walter Reed Cohort Study.
    Mitchell JD; Paisley R; Moon P; Novak E; Villines TC
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1799-1806. PubMed ID: 29153576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
    JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
    Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
    Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
    Berman AN; Biery DW; Besser SA; Singh A; Shiyovich A; Weber BN; Huck DM; Divakaran S; Hainer J; Kaur G; Blaha MJ; Cannon CP; Plutzky J; Januzzi JL; Booth JN; López JAG; Kent ST; Nasir K; Di Carli MF; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2024 Mar; 83(9):873-886. PubMed ID: 38418000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Atherosclerotic Cardiovascular Disease Risk in Patients With Cancer: A Population-Based Study.
    Yang L; Zhang N; Yue Q; Song W; Zheng Y; Huang S; Qiu J; Tse G; Li G; Wu S; Liu T
    Curr Probl Cardiol; 2023 Jul; 48(7):101693. PubMed ID: 36924906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
    Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
    Kato ET; Morrow DA; Guo J; Berg DD; Blazing MA; Bohula EA; Bonaca MP; Cannon CP; de Lemos JA; Giugliano RP; Jarolim P; Kempf T; Kristin Newby L; O'Donoghue ML; Pfeffer MA; Rifai N; Wiviott SD; Wollert KC; Braunwald E; Sabatine MS
    Eur Heart J; 2023 Jan; 44(4):293-300. PubMed ID: 36303404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
    Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.